Market accessOfficial
IGJ lifts restrictions on Jiaxing Tianhe BAL flush syringes made from 2026 onwards
🇳🇱 IGJ · Thu 19 Nov 2026
Dutch inspectorate says use, distribution and quarantine rules under FSCA TH-FSCA-2026001 no longer apply to 10 ml syringe batches produced on or after 1 January 2026, subject to date verification.
The Dutch healthcare inspectorate IGJ has announced that the restrictions on use and distribution, and the quarantine obligations, set out in field safety corrective action TH-FSCA-2026001 are being lifted for part of the affected stock. The product is the BAL Flush Syringe SS, 10 ml, made by Jiaxing Tianhe Pharmaceutical Co., Ltd.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (IGJ). AI-assisted; check the source before acting.
More Market access
All →
SÚKL publishes draft Czech reimbursement list effective 20 November 2026
🇨🇿 SÚKL · Fri 20 Nov 2026
SÚKL launches expanded ASTERx system for pricing and reimbursement proceedings, retires Verso
🇨🇿 SÚKL · Fri 20 Nov 2026
AIFA publishes outcomes of November Scientific and Economic Committee meeting
🇮🇹 AIFA · Fri 20 Nov 2026
Nova Biomedical starts field safety action on StatStrip ketone test strips over QC failures
🇳🇱 IGJ · Thu 19 Nov 2026
Getinge recalls CARDIOSAVE balloon pumps in Canada over reversed-polarity capacitors
🇨🇦 Health Canada · Thu 19 Nov 2026
ICU Medical recalls Portex endotracheal tubes in Canada over plasticizer variability in resin
🇨🇦 Health Canada · Thu 19 Nov 2026